We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Public Citizen Calls for Boxed Warning on Top-Selling Hypertension Drugs
Public Citizen Calls for Boxed Warning on Top-Selling Hypertension Drugs
October 12, 2012
Public Citizen is urging the FDA to require boxed warnings on the labels of many top-selling hypertension drugs, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs) and Novartis’ aliskiren, to warn against their use in combination.